PTC Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on PTC Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how PTC Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with PTC Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on PTC Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into PTC Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Michael Schmertzler
Chairman Executive BoardMr. Michael Schmertzler has been the Chairman of the company since 2004. Prior to this, he served as the Managing Director at Aries Advisors LLC. Previously, he served as the Chairman of the investment committee of Credit Suisse First Boston Equity Partners LP from 2001 to 2015. He also served as the Co-Head of United States and Canadian Private Equity at Credit Suisse First Boston from 1997 to 2001. Previously, he served in several management roles at Morgan Stanley. He also served as the Managing Director and Chief Financial Officer at Lehman Brothers Kuhn Loeb.
Matthew B. Klein, MD
Director; Chief Executive Officer Executive BoardDr. Matthew B. Klein has been the Chief Executive Officer and Director of the company since 2023. Prior to this, he served as the Chief Operating Officer of the company. Previously, he served as the Chief Development Officer of the company. He also served as the Chief Executive Officer and Chief Medical Officer of BioElectron Technology Corp. He served as the Auth-Washington Research Chair of Restorative Burn Surgery at the University of Washington.
Pierre Gravier
Chief Financial Officer Senior ManagementMr. Pierre Gravier has been the Chief Financial Officer of the company since 2023. Prior to this, he served as the Managing Director of Perella Weinberg Partners. Previously, he served as a Healthcare Investment Banker at Barclays Capital. He also served as the Director at Cassava Sciences Inc.
Christine Utter
Head - People Services; Chief Accounting Officer; Senior Vice President Senior ManagementMs. Christine Utter has been the Head of People Services, Senior Vice President, and Chief Accounting Officer of the company since 2019. Prior to this, she served as the company's Assistant Controller of the company. Previously, he served as the Principal Financial Officer of the company. He also served as the Assistant Corporate Controller of Barrier Therapeutics and Financial Analyst at Engelhard Corp.
Linda Montella-Carter
Senior Vice President; Chief Information Officer Senior ManagementMs Linda Montella-Carter is the Senior Vice President and Chief Information Officer of the company. Prior to this, she served as a Management Consultant at Merck & Co. Previously, she had over 27 years of experience in pharmaceutical and manufacturing environments.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer